UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How I treat relapsed acute lymphoblastic leukemia in the pediatric population

Blood, 2020-10, Vol.136 (16), p.1803-1812

2020

Volltextzugriff (PDF)

Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Journal of clinical oncology, 2020-06, Vol.38 (17), p.1897-1905

2020

Volltextzugriff (PDF)

Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232

Blood, 2015-08, Vol.126 (8), p.964-971

2015

Volltextzugriff (PDF)

Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia

Nature genetics, 2013-03, Vol.45 (3), p.290-294

2013

Volltextzugriff (PDF)

FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631

Leukemia, 2021-05, Vol.35 (5), p.1279-1290

2021

Volltextzugriff (PDF)

Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk

Nature communications, 2019-11, Vol.10 (1), p.5348-9, Article 5348

2019

Volltextzugriff (PDF)

Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia

Nature communications, 2024-08, Vol.15 (1), p.7425-17, Article 7425

2024

Volltextzugriff (PDF)

Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia

Blood, 2012-05, Vol.119 (22), p.5201-5210

2012

Volltextzugriff (PDF)

Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia

Haematologica (Roma), 2021-12, Vol.107 (8), p.1746-1757

2021

Volltextzugriff (PDF)

Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232

Leukemia, 2022-03, Vol.36 (3), p.648-655

2022

Volltextzugriff (PDF)

Intrachromosomal Amplification of Chromosome 21 Is Associated With Inferior Outcomes in Children With Acute Lymphoblastic Leukemia Treated in Contemporary Standard-Risk Children's Oncology Group Studies: A Report From the Children's Oncology Group

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3397-3402

2013

Volltextzugriff (PDF)

Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group

Journal of clinical oncology, 2017-08, Vol.35 (23), p.2700-2707

2017

Volltextzugriff (PDF)

Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331

Journal of clinical oncology, 2021-05, Vol.39 (14), p.1540-1552

2021

Volltextzugriff (PDF)

Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932

Leukemia, 2023-06, Vol.37 (6), p.1375-1378

2023

Volltextzugriff (PDF)

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Current Practice and Future Directions

Cancers, 2021-04, Vol.13 (8), p.1847

2021

Volltextzugriff (PDF)

Outstanding outcomes in infants with KMT2A -germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial

Haematologica (Roma), 2022-05, Vol.107 (5), p.1205-1208

2022

Volltextzugriff (PDF)

Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia

Blood, 2016-02, Vol.127 (5), p.558-564

2016

Volltextzugriff (PDF)

Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations

Blood, 2021-03, Vol.137 (11), p.1550-1552

2021

Volltextzugriff (PDF)

Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG

Haematologica (Roma), 2019-05, Vol.104 (5), p.986-992

2019

Volltextzugriff (PDF)

Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot Study

Journal of clinical oncology, 2008-08, Vol.26 (22), p.3756-3762

2008

Volltextzugriff (PDF)

T-cell acute lymphoblastic leukemia

Hematology, 2016-12, Vol.2016 (1), p.580-588

2016

Volltextzugriff (PDF)

Clinical and Laboratory Biology of Childhood Acute Lymphoblastic Leukemia

The Journal of pediatrics, 2012, Vol.160 (1), p.10-18

2012

Volltextzugriff (PDF)

Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia

Blood, 2008-11, Vol.112 (10), p.4178-4183

2008

Volltextzugriff (PDF)

Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside

1st ed. 2022., 2021

Volltextzugriff (PDF)

1 – 25 von 431

Suche als RSS-Feed

Aktive Filter

PublikationsformDissertationen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(383)
Mit Volltextzugriff
(362)

Publikationsform

Artikel
(408)
Buchkapitel
(22)
Bücher
(1)

Sprache

Englisch
(431)
Japanisch
(34)
Polnisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(180)
Life Sciences & Biomedicine
(177)
Humans
(162)
Child
(136)
Oncology
(106)
Hematology
(102)
Male
(87)
Female
(84)
Child, Preschool
(73)
Adolescent
(70)
Acute Lymphoblastic Leukemia
(62)
Pediatrics
(61)
Infant
(53)
Leukemia
(50)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(45)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Genetics
(43)
Adult
(39)
Young Adult
(34)
Children
(33)
Prognosis
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(162)
Journal Of Clinical Oncology
(69)
Pediatric Blood & Cancer
(30)
The Hematologist
(18)
Leukemia
(12)
Cancer
(7)
Cancer Research
(7)
The hematologist
(7)
Haematologica
(6)
Journal Of Pediatric Hematology/oncology
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

How I treat relapsed acute lymphoblastic leukemia in the pediatric population

Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232

Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia

FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631

Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk

Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia

Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia

Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia

Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232

Intrachromosomal Amplification of Chromosome 21 Is Associated With Inferior Outcomes in Children With Acute Lymphoblastic Leukemia Treated in Contemporary Standard-Risk Children's Oncology Group Studies: A Report From the Children's Oncology Group

Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group

Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331

Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Current Practice and Future Directions

Outstanding outcomes in infants with KMT2A -germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial

Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations

Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG

Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot Study

T-cell acute lymphoblastic leukemia

Clinical and Laboratory Biology of Childhood Acute Lymphoblastic Leukemia

Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia

Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside

Aktive Filter

Suchergebnisse filtern